Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in malignant lymphomas.

Sarah E Henrickson, Elena M Hartmann, German Ott

    Advances in Experimental Medicine and Biology
    |February 3, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma.

    Cell death discovery·2022
    Same author

    First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.

    HemaSphere·2022
    Same author

    MYC multimers shield stalled replication forks from RNA polymerase.

    Nature·2022
    Same author

    Panel Sequencing of Primary Cutaneous B-Cell Lymphoma.

    Cancers·2022
    Same author

    Vitamin D Receptor Expression Is Significantly Decreased in Bone Metastases Compared to Matched Primary Breast Cancer Tumours.

    Cancer investigation·2022
    Same author

    Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

    Cancers·2022

    DNA microarrays reveal gene expression patterns in hematological malignancies, improving prognosis and treatment strategies. This gene expression profiling offers new insights into leukemias and lymphomas, advancing personalized medicine.

    Area of Science:

    • Genomics
    • Molecular Biology
    • Oncology

    Background:

    • The human genome's decoding has transformed clinical medicine and biomedical research.
    • DNA microarrays are increasingly used to analyze gene expression patterns in diseases.
    • Gene expression profiling has significantly impacted hematological malignancy research.

    Purpose of the Study:

    • To highlight the impact of gene expression profiling in understanding hematological malignancies.
    • To discuss the discovery of prognostic tools and molecular subgroups in lymphomas.
    • To explore the clarification of molecular mechanisms in various blood cancers.

    Main Methods:

    • Utilizing DNA microarrays for gene expression profiling.
    • Analyzing gene expression patterns in hematological malignancies.

    Related Experiment Videos

  • Identifying molecular subgroups and prognostic indicators.

    • Main Results:

    • Discovery of prognostic tools like Zap-70 in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
    • Identification of two molecular subgroups in Diffuse Large B-cell Lymphoma (DLBCL) with different outcomes.
    • Association of molecular signatures with clinical course in Follicular Lymphoma (FL).
    • Clarification of molecular mechanisms in Mantle Cell Lymphoma (MCL), including cell cycle and DNA damage pathways.

    Conclusions:

    • Gene expression profiling has yielded significant discoveries in leukemias, lymphomas, and other cancers.
    • Further research is needed to fully understand and translate these findings.
    • The clinical application of gene expression profiling in oncology is still in its early stages.